Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

17.780
-1.520-7.88%
Volume:260.40K
Turnover:4.65M
Market Cap:18.26B
PE:-20.44
High:19.300
Open:19.300
Low:17.400
Close:19.300
52wk High:32.620
52wk Low:15.250
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:0.89
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-9.32%
ROA:-2.89%
PB:2.63
PE(LYR):-20.44
PS:5.16

Loading ...

Junshi Biosciences Swings to Profit on 45% Revenue Surge in 1H 2026, Boosted by Toripalimab Sales and Licensing Income

Bulletin Express
·
Sep 24

Shanghai Junshi Biosciences Grants 715,000 A-Share Options

MT Newswires Live
·
Sep 24

Asian Growth Companies With High Insider Ownership September 2026

Simply Wall St.
·
Sep 22

AH Premium Ranking Summary | September 21

Stock News
·
Sep 21

Junshi Bio's Payables Turnover Exceeds 700 Days, Raising Concerns Over Prolonged Use of Small Supplier Funds

Deep News
·
Sep 17

Junshi Biosciences Surges Over 3% on Plans to Launch Pivotal Phase III Trials for Two Bispecific Antibody Drugs This Year

Stock News
·
Sep 14

AH Share Premium Rankings: September 10 Market Close Update

Stock News
·
Sep 10

AH Share Premium Rankings as of September 9 Trading Close

Stock News
·
Sep 09

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Stock News
·
Sep 07

Junshi Biosciences Schedules 2026 Interim Results Conference Call

Deep News
·
Sep 04

Junshi Bio Schedules 2026 Interim Results Briefing for 14 September

Bulletin Express
·
Sep 04

AH Premium Rankings Update: September 3 Market Close

Stock News
·
Sep 03

AH Premium Rankings for September 2nd Market Close

Stock News
·
Sep 02

AH Share Premium Rankings for September 1st

Stock News
·
Sep 01

Shanghai Junshi Biosciences Says Shanghai Tanying Investment Plans Reduction Stake

MT Newswires Live
·
Aug 31

AH Share Premium Report: August 31 Market Close

Stock News
·
Aug 31

Junshi Bio: Shanghai Tanying Plans to Cut Up to 2% Stake by December 2026

Bulletin Express
·
Aug 31

AH Premium Rankings for August 27: A Market Overview

Stock News
·
Aug 27

Shanghai Junshi Biosciences Estimates 35 Million Yuan in Related-Party Transactions

MT Newswires Live
·
Aug 27

Press Release: Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates

Dow Jones
·
Aug 27